What type of patients do you accept?
We do not provide Parkinson’s disease care to the following patients:
- Institutionalized patients with Parkinson’s disease (nursing homes, etc.)
- Patients over 75 years old
- Patients who are taking traditional Parkinson's disease drugs with a total dosing value of L-dopa greater than 1,200 mg per day.
How is the Hinz Protocol™ approach different?
Medicine recognizes L-dopa as the most effective Parkinson’s disease treatment available. All other drugs are second class and not as effective. Our method of care is not new; we use L-dopa. The difference is standard of care in medicine uses another drug packaged in combination with the L-dopa to manage problems that have plagued treatment with L-dopa for over 50 years (see below). The advantage of our approach is the ability to manage and eliminate problems and side effects induced by drug packaged with L-dopa.
What problems can depletion of vitamin B6 by traditional Parkinson's disease drugs cause?
- Induce nutritional deficiencies of vitamin B6 dependent processes.
- Can change dopamine precursors from a nutrient to a drug.
- Linked to the increasing death rate among Parkinson’s disease patients.
- Can make Parkinson’s disease symptoms worse.
- Can accelerate the permanent brain damage of Parkinson’s disease.
- Can cause dopamine precursors to quit working.
- Can induce dyskinesias and choreiform movement disorder during treatment.